LifeTech Seeks More Time to Restore Independent Board Compliance

LifeTech Scientific Corporation ( (HK:1302) ) has provided an update.

LifeTech Scientific Corporation, a Cayman Islands-incorporated issuer listed in Hong Kong, is governed by a board that includes executive, non-executive and independent non-executive directors, who also serve on the audit, nomination and remuneration committees. The company’s compliance with Hong Kong Listing Rules depends on maintaining adequate independent representation on these committees to ensure appropriate corporate governance and regulatory oversight.

Following the resignation of an independent non-executive director, LifeTech has fallen below the minimum requirements for independent board and committee membership and has been unable to fill the vacancy within the prescribed three‑month grace period. The company has conducted an extensive search but now seeks a waiver and an extension from the Stock Exchange to regain compliance, pledging continued efforts to appoint a suitable candidate and vowing to update the market once the governance gaps are resolved.

The delay in appointing a replacement underscores the challenges of sourcing qualified independent directors who meet regulatory standards and board needs, highlighting governance pressures on smaller issuers. Until the vacancy is filled and regulatory waivers, if any, are granted, stakeholders face a period in which the company’s formal compliance with listing governance requirements remains in transition, although the board signals its intention to rectify the situation as soon as practicable.

More about LifeTech Scientific Corporation

LifeTech Scientific Corporation is a Cayman Islands-incorporated company listed in Hong Kong that operates through a group structure, overseen by a board comprising executive, non-executive and independent non-executive directors. The group is subject to Hong Kong Listing Rules governing board composition and the structure of key governance committees, including audit, nomination and remuneration committees.

The company’s governance framework relies on maintaining a sufficient number of independent non-executive directors to chair and populate these committees, ensuring regulatory compliance and oversight. Recent board changes have triggered obligations under multiple Listing Rules, requiring timely appointments to restore the mandated balance of independent oversight on the board and its committees.

Average Trading Volume: 17,589,817

Technical Sentiment Signal: Buy

Current Market Cap: HK$8.12B

For detailed information about 1302 stock, go to TipRanks’ Stock Analysis page.